Democrat senators give Trump's pick for health secretary a fierce grilling - but he is still expected to be confirmed ...

Smithfield Foods' CEO says he hopes that everything the company has done to make working in its plants more attractive ever ...

The Special Investigating Unit (SIU) is pursuing the recovery of R33. 4 million paid to Cuba for the Interferon alfa-2b drug, ...

Ever since the novel coronavirus reached the United States five years ago, it has unleashed punishing winter waves of illness ...

Investors concerned about sticky inflation should look to high-yield dividend stocks in sectors that will continue to ...

TCU basketball is better off because of Jamie Dixon’s time at his alma mater, but to win this team needs real money.

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

A nationwide surge in pertussis has reached Erie County, which reported 23 cases of the vaccine-preventable disease in 2024.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...